Stoke Therapeutics Files Q1 2025 10-Q
Ticker: STOK · Form: 10-Q · Filed: May 13, 2025 · CIK: 1623526
| Field | Detail |
|---|---|
| Company | Stoke Therapeutics, Inc. (STOK) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Stoke Therapeutics filed its 10-Q for Q1 2025 on May 13th. Check financials.
AI Summary
Stoke Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly ASOthera Pharmaceuticals, Inc., is involved in pharmaceutical preparations. Key financial data and operational details are presented in this filing, which was submitted on May 13, 2025.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Stoke Therapeutics, Inc., crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Stoke Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 001-38938 — SEC File Number (SEC file number for Stoke Therapeutics, Inc.)
Key Players & Entities
- Stoke Therapeutics, Inc. (company) — Filer of the 10-Q
- ASOthera Pharmaceuticals, Inc. (company) — Former name of Stoke Therapeutics, Inc.
- 20250331 (date) — Period of report for the 10-Q
- 20250513 (date) — Filing date of the 10-Q
- Acadia Pharmaceuticals Inc. (company) — Mentioned in relation to a specific date range
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date was May 13, 2025.
What was Stoke Therapeutics, Inc. previously named?
The company was formerly known as ASOthera Pharmaceuticals, Inc.
What is the Standard Industrial Classification (SIC) code for Stoke Therapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Stoke Therapeutics, Inc.?
The business address is 45 Wiggins Avenue, Bedford, MA 01730.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Stoke Therapeutics, Inc. (STOK).